BANK OF AMERICA CORP /DE/
BankPosition in VRDN — Viridian Therapeutics, Inc.\DE
CIK 70858
CHARLOTTE, NC
Position in VRDN
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$22,760,308
-$8,052,131 QoQ
Shares Held
1,163,615
+17.5% QoQ
Ownership
1.13%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
20 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in VRDN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,548,750,242 across 347 Biotechnology names. VRDN ranks #71 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in VRDN
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $22,760,308 | 1,163,615 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $30,812,439 | 990,117 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $5,303,477 | 245,759 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $3,227,197 | 230,844 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,428,056 | 180,123 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $4,737,039 | 247,107 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $4,117,044 | 180,969 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,740,905 | 210,677 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $8,330,082 | 475,733 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $6,238,835 | 286,448 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $3,148,118 | 205,223 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $4,252,484 | 178,751 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $6,482,642 | 254,821 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $3,370,190 | 115,378 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $1,162,834 | 56,696 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $135,704 | 11,729 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $329,731 | 17,833 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $188,090 | 9,514 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $2,845 | 173 | Shares | Defined | 2021-11-15 | |
| 2021-03-31 | $267 | 16 | Shares | Defined | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||